AF
TMO icon

Arrow Financial’s Thermo Fisher Scientific TMO Stock Holding History

Arrow Financial’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.43M Sell
4,940
-183
-4% -$99.3K 0.24% 64
2025
Q4 		$2.97M Sell
5,123
-263
-5% -$149K 0.3% 54
2025
Q3 		$2.61M Buy
5,386
+257
+5% +$120K 0.27% 59
2025
Q2 		$2.08M Buy
5,129
+260
+5% +$109K 0.22% 68
2025
Q1 		$2.42M Sell
4,869
-3,235
-40% -$1.75M 0.27% 60
2024
Q4 		$4.22M Buy
8,104
+8
+0.1% +$4.4K 0.4% 54
2024
Q3 		$5.01M Sell
8,096
-1,082
-12% -$640K 0.46% 43
2024
Q2 		$5.08M Sell
9,178
-580
-6% -$332K 0.5% 42
2024
Q1 		$5.67M Sell
9,758
-149
-2% -$83.6K 0.56% 39
2023
Q4 		$5.26M Sell
9,907
-34
-0.3% -$16.5K 0.55% 39
2023
Q3 		$5.03M Sell
9,941
-1,361
-12% -$725K 0.59% 41
2023
Q2 		$5.9M Sell
11,302
-158
-1% -$85.3K 0.71% 34
2023
Q1 		$6.61M Buy
11,460
+51
+0.4% +$28.7K 0.86% 29
2022
Q4 		$6.28M Sell
11,409
-100
-0.9% -$53K 0.85% 27
2022
Q3 		$5.84M Sell
11,509
-32
-0.3% -$17.9K 0.85% 26
2022
Q2 		$6.27M Sell
11,541
-930
-7% -$512K 0.86% 27
2022
Q1 		$7.37M Buy
12,471
+1,322
+12% +$759K 0.88% 23
2021
Q4 		$7.44M Sell
11,149
-961
-8% -$600K 0.88% 22
2021
Q3 		$6.92M Sell
12,110
-250
-2% -$137K 0.89% 22
2021
Q2 		$6.24M Sell
12,360
-100
-0.8% -$47.2K 0.79% 27
2021
Q1 		$5.69M Sell
12,460
-77
-0.6% -$36.8K 0.75% 30
2020
Q4 		$5.84M Sell
12,537
-916
-7% -$429K 1.14% 25
2020
Q3 		$5.94M Sell
13,453
-897
-6% -$371K 1.26% 20
2020
Q2 		$5.2M Sell
14,350
-226
-2% -$75.8K 1.13% 23
2020
Q1 		$4.13M Buy
14,576
+63
+0.4% +$19.9K 0.98% 26
2019
Q4 		$4.71M Buy
14,513
+496
+4% +$150K 0.92% 31
2019
Q3 		$4.08M Buy
14,017
+385
+3% +$110K 0.85% 35
2019
Q2 		$4M Buy
13,632
+235
+2% +$64.7K 0.86% 36
2019
Q1 		$3.67M Sell
13,397
-33
-0.2% -$8.21K 0.85% 34
2018
Q4 		$3M Sell
13,430
-75
-0.6% -$17.6K 0.77% 38
2018
Q3 		$3.3M Buy
13,505
+942
+7% +$217K 0.69% 43
2018
Q2 		$2.6M Buy
12,563
+1,644
+15% +$349K 0.58% 46
2018
Q1 		$2.25M Buy
10,919
+6,384
+141% +$1.34M 0.52% 52
2017
Q4 		$861K Buy
4,535
+310
+7% +$59.4K 0.2% 103
2017
Q3 		$800K Buy
4,225
+1,897
+81% +$344K 0.19% 104
2017
Q2 		$406K Buy
2,328
+1,728
+288% +$290K 0.1% 138
2017
Q1 		$92K Buy
600
+260
+76% +$39.7K 0.02% 180
2016
Q4 		$48K Hold
340
– – 0.01% 211
2016
Q3 		$54K Hold
340
– – 0.01% 208
2016
Q2 		$50K Hold
340
– – 0.01% 215
2016
Q1 		$48K Buy
340
+300
+750% +$40.2K 0.01% 221
2015
Q4 		$6K Hold
40
– – ﹤0.01% 327
2015
Q3 		$5K Hold
40
– – ﹤0.01% 313
2015
Q2 		$5K Buy
40
+20
+100% +$2.61K ﹤0.01% 317
2015
Q1 		$3K Buy
+20
New +$2.58K ﹤0.01% 353
2014
Q4 		– Sell
-72
Closed -$9K – 391
2014
Q3 		$9K Buy
+72
New +$8.75K ﹤0.01% 324

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrow Financial's TMO Position: Q1 2026 in Review

Arrow Financial reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q1 2026, selling an estimated $99.3K and leaving 4,940 shares worth $2.43M. The position accounts for 0.24% of the portfolio, ranked #64.

Arrow Financial first reported a position in TMO in Q3 2014 and has held it in 46 quarters since. The position peaked at $7.44M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Arrow Financial held 4,940 shares of Thermo Fisher Scientific worth $2.43M as of Q1 2026.
  • Arrow Financial sold 183 Thermo Fisher Scientific shares in Q1 2026, an estimated $99.3K.
  • Thermo Fisher Scientific made up 0.24% of Arrow Financial's portfolio in Q1 2026, its #64 holding.
  • Arrow Financial first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 46 quarters since.
  • Arrow Financial's Thermo Fisher Scientific position peaked at $7.44M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.